EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease

Neurobiology of Aging

Volumn 29, Issue 6, 2008, Pages 819-827

  Ponomareva, N V ^a   Korovaitseva, G I ^b   Rogaev, E I ^b,c  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

^b MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; EEG; Genetic predisposition; Hyperventilation

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THETA RHYTHM;

AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DEMENTIA; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROENCEPHALOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RUSSIA; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 42649121653     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.12.019     Document Type: Article

References (53)

1. Ankri J., and Poupard M. Prevalence and incidence of dementia in the very elderly. Review of the literature. Rev. Epidemiol. Sante Publique 51 3 (2003) 349-360
2. Arai T., Ikeda K., Akiyama H., Haga C., Usami M., Sahara N., Iritani S., and Mori H. A high incidence of apolipoprotein E epsilon4 allele in middle-aged nondemented subjects with cerebral amyloid beta protein deposits. Acta Neuropathol. 97 1 (1999) 82-84
3. Babiloni C., Benussi L., Binetti G., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., Ferri R., Frisoni G., Ghidoni R., Miniussi C., Rodriguez G., Romani G., Squitti R., Vetriglia M., and Rossini P. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study. Ann. Neurol. 59 2 (2006) 323-334
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 31 2 (1992) 119-130
5. Beisiengel U., Arlt S., Daher D., Schippling S., Mann U., Muller-Thomsen T., Sturenburg H.-J., Buhmann C., Bernhardt R., Mann W.A., and Kontush A. Apolipoprotein E genotype determines the lipid level in and oxidizability of human cerebrospinal fluid. Soc. Neurosci. Abstr. 23 (1997) 1834
6. Bickford R. Activation procedures and special electrodes. In: Klass D. (Ed). Current Practice of Clinical Electroencephalography (1979), Raven Press, New York 269-305
7. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18 4 (1997) 351-357
8. Cook I.A., O'Hara R., Uijtdehaage S.H., Mandelkern M., and Leuchter A.F. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr. Clin. Neurophysiol. 107 6 (1998) 408-414
9. Dager S.R., Strauss W.L., Marro K.I., Richards T.L., Metzger G.D., and Artru A.A. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am. J. Psychiatry 152 5 (1995) 666-672
10. Farrer L.A., Cupples A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278 16 (1997) 1349-1356
11. Fokin V.F., Ponomareva N.V., Orlov O.N., Lideman R.R., and Erin A.N. Relations between electricity reactions of the brain and lipid peroxidation in patients with pathological aging. Bull. Exp. Biol. Med. 54 6 (1989) 682-684 (rus)
12. Folstein M., Folstein S., and McHugh P. 'Mini-Mental State': a practical method for grading the cognitive state of patients for clinician. J. Psychiatry Res. 12 3 (1975) 189-198
13. Ghebremedhin E., Schultz C., Braak E., and Braak H. High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp. Neurol. 153 (1998) 152-155
14. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., and Hardy J. Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
15. Gullapally D., and Fountain N. Clinical correlation of occipital intermittent rhythmic delta activity. J. Clin. Neurophysiol. 20 (2003) 35-41
16. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Denis A., and Evans D.A. Alzheimer disease in the US Population. Prevalence estimates using the 2000 Census. Arch. Neurol. 60 (2003) 1119-1122
17. Hogan M.J., Swanwick G.R., Kaiser J., Rowan M., and Lawlor B. Memory-related EEG power and coherence reductions in mild Alzheimer's disease. Int. J. Psychophysiol. 49 2 (2003) 147-163
18. Huang C., Wahlund L., Dierks T., Julin P., Winblad B., and Jelic V. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin. Neurophysiol. 111 11 (2000) 1961-1967
19. Jelic V., Julin P., Shigeta M., Nordberg A., Lannfelt L., Winblad B., and Wahlund L.-O. Apolipoprotein E epsilon 4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J. Neurol. Neurosurg. Psychiatry 63 1 (1997) 59-65
20. Jibiki I., Kurokawa K., Matsuda H., Fukushima T., Yamaguchi N., and Hisada K. Widespread reduction of regional cerebral blood flow during hyperventilation-induced EEG slowing ('buildup'). Observation from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 26 3 (1992) 120-124
21. John E.R., Ahn H., Prichep L.S., Trepetin M., Brown D., and Kaye H. Developmental equations for the electroencephalogram. Science 210 (1980) 1255-1258
22. Kennely J., Penovich P., and Moore-Nease S. EEG and Spectral analysis in acute hyperventilation. Electroencephalogr. Clin. Neurophysiol. 63 (1986) 98-106
23. Korovaitseva G.I., Bukina A., Farrer L.A., and Rogaev E.I. Presenilin polymorphisms in Alzheimer's disease. Lancet 350 (1997) 959
24. LaFerla F.M. The Alzheimer's beta-amyloid peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Behav. Pharmacol. 6 Suppl. (1995) 55 (Abstact)
25. Lehtovirta M., Partanen J., Kononen M., Soininen H., Helisalmi S., Mannermaa A., Ryynanen M., Hartikainen P., and Riekkinen P. A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism. Dement. Geriatr. Cogn. Disord. 11 1 (2000) 29-35
26. Levy-Lahad E., Wasco W., Poorkaj P., Romano D., Oshima J., Pettingell W., Yu C.E., Jondro P., Schmidt S., and Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
27. Lobo A., Launer L.J., Frantaglione L., Andersen K., Di Carlo A., Breteler M.M., Copeland J.R., Dartigues J.F., Jagger C., Martinez-Lage J., Soininen H., and Hofman A. A collaborative study of population-based cohorts. Prevalence of dementia and major subtypes in Europe. Neurologic Diseases in the Elderly Research Group. Neurology 54 (2000) S4-S9
28. Maddock R.J. The lactic acid response to alkalosis in panic disorder. J. Neuropsychiatry Clin. Neurosci. 13 (2001) 22-34
29. Makiranta M.J., Ruohonen J., Suominen K., Sonkajarvi E., Salomaki T., Kiviniemi V., Seppanen T., Alahuhta S., Jantti V., and Tervonen O. BOLD-contrast functional MRI signal changes related to intermittent rhythmic delta activity in EEG during voluntary hyperventilation-simultaneous EEG and fMRI study. Neuroimage 22 1 (2004) 222-231
30. Marra C., Bizzarro A., Daniele A., De Luca L., Ferraccioli M., Valenza A., Brahe C., Tiziano F., Gainotti G., and Masullo C. Apolipoprotein E e4 allele differently affects the patterns of neuropsychological presentation in early and late-onset Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 18 2 (2004) 125-131
31. Mattson M., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 2 (1992) 376-389
32. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease. Neurology 34 7 (1984) 933-944
33. Moretti D.V., Babiloni C., Binetti G., Cassetta E., Dal Forno G., Ferreric F., Ferri R., Lanuzza B., Miniussi C., Nobili F., Rodriguez G., Salinari S., and Rossini P.M. Individual analysis of EEG frequency and band power in mild Alzheimer's disease. Clin. Neurophysiol. 115 2 (2004) 299-308
34. Niedermeyer E. Focal and generalized seizure discharges in the electroencephalogram and their response to intravenous diazepam. Int. Med. Dig. 7 (1972) 49-61
35. Ohm T.G., Müller H., Braak H., and Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64 (1994) 209-217
36. Ponomareva N.V., Fokin V.F., Selesneva N.D., and Voskresenskaia N.I. Possible neurophysiological markers of genetic predisposition to Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9 5 (1998) 267-273
37. Ponomareva N.V., Selesneva N.D., and Jarikov G.A. EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 48 3 (2003) 152-159
38. Prichep L.S., John E.R., Ferris S.H., Rausch L., Fang Z., Cancro R., Torossian C., and Reisberg B. Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol. Aging 27 (2006) 471-481
39. Qiu Z., Crutcher K.A., Hyman B.T., and Rebeck G.W. ApoE isoforms affect neuronal N-m ethyl-d-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122 2 (2003) 291-303
40. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., and Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. PNAS 101 1 (2004) 284-289
41. Rodriguez G., Nobili F., Rocca G., De Carli F., Gianelli M.V., and Rosadini G. Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls. Dement. Geriatr. Cogn. Disord. 9 5 (1998) 274-283
42. Rogaev E.I. Genetic factors and a polygenic model of Alzheimer's disease. Genetika 35 11 (1999) 1558-1571
43. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov L., Cohen D., Lannfeldt L., Fraser P.E., Rommens J.M., and St George-Hyslop P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 6543 (1995) 775-778
44. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
45. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo C.H., Pericak-Vance M.A., Goldgaber D., and Roses A. Increased amyloid ß-peptide deposition in cerebral cortex as a consequence of an apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9649-9653
46. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., and Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
47. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., La Rue A., Adamson C.F., and Chang L. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273 (1995) 942-947
48. Sneddon R., Shankle W.R., Hara J., Rodriquez A., Hoffman D., and Saha U. EEG detection of early Alzheimer's disease using psychophysical tasks. Clin. EEG Neurosci. 36 3 (2005) 141-150
49. Steriade M., Gloor P., Llinas R., Lopes da Silva F., and Mesulam M. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr. Clin. Neurophysiol. 76 (1990) 481-508
50. Stevens A., Kircher T., Nickola M., Bartels M., Rosellen N., and Wormstall H. Dynamic regulation of EEG power and coherence is lost early and globally in probable DAT. Eur. Arch. Psychiatry Clin. Neurosci. 251 5 (2001) 199-204
51. Van der Worp H.B., Kraaier V., Wieneke G.H., and Van Huffelen A.C. Quantitative EEG during progressive hypocarbia and hypoxia. Hyperventilation-induced EEG changes reconsidered. Electroencephalogr. Clin. Neurophysiol. 79 (1991) 335-341
52. Versavel M., Leonard J.P., and Herrmann W.M. Standard operating procedure for registration and computer-supported evaluation of pharmaco-EEG data. Neuropsychobiology 32 (1995) 166-170
53. Zenkov L.R. Clinical Epileptologia (2002), MIA, Moscow (rus)